Literature DB >> 23000206

Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE).

Cyrus Biazar1, Johanna Sigges, Nikolaos Patsinakidis, Vincent Ruland, Susanne Amler, Gisela Bonsmann, Annegret Kuhn.   

Abstract

In this prospective, cross-sectional, multicenter study, we assessed clinical and laboratory characteristics from patients with cutaneous lupus erythematosus (CLE) using the Core Set Questionnaire of the European Society of Cutaneous Lupus Erythematosus (EUSCLE). 1002 (768 females, 234 males) patients with different subtypes of CLE, such as acute CLE (ACLE, 304 patients), subacute CLE (SCLE, 236 patients), chronic CLE (CCLE, 397 patients), and intermittent CLE (ICLE, 65 patients), from 13 European countries were collected and statistically analyzed by an SPSS database. The main outcome measures included gender, age at onset of disease, LE-specific and LE-nonspecific skin lesions, photosensitivity, laboratory features, and the criteria of the American College of Rheumatology (ACR) for the classification of systemic lupus erythematosus. The mean age at onset of disease was 43.0±15.7 years and differed significantly between the CLE subtypes. In 347 (34.6%) of the 1002 patients, two or more CLE subtypes were diagnosed during the course of the disease and 453 (45.2%) presented with LE-nonspecific manifestations. Drug-induced CLE and Sjögren's Syndrome had the highest prevalence in SCLE patients (13.1% and 14.0%, respectively). Photosensitivity was significantly more frequent in patients with ACLE, SCLE, and ICLE compared with those with CCLE. The detection of antinuclear antibodies such as anti-Ro/SSA and anti-La/SSB antibodies revealed further significant differences between the CLE subtypes. In summary, the EUSCLE Core Set Questionnaire and its database facilitate the analysis of clinical and laboratory features in a high number of patients with CLE and will contribute to standardized assessment and monitoring of the disease in Europe.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23000206     DOI: 10.1016/j.autrev.2012.08.019

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  31 in total

Review 1.  Cutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus.

Authors:  Jasmine N Stannard; J Michelle Kahlenberg
Journal:  Curr Opin Rheumatol       Date:  2016-09       Impact factor: 5.006

2.  Response letter to 'chronic cutaneous lupus erythematosus induced by 5-fluorouracil'.

Authors:  Robert Borucki; Victoria P Werth
Journal:  Expert Rev Clin Pharmacol       Date:  2020-07-17       Impact factor: 5.045

3.  Autoimmune Diseases in Patients With Cutaneous Lupus Erythematosus.

Authors:  Elaine Kunzler; Linda S Hynan; Benjamin F Chong
Journal:  JAMA Dermatol       Date:  2018-06-01       Impact factor: 10.282

Review 4.  Autoimmunity in 2013.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

Review 5.  Cutaneous Lupus Erythematosus: Progress and Challenges.

Authors:  Amy J Petty; Lauren Floyd; Christopher Henderson; Matilda W Nicholas
Journal:  Curr Allergy Asthma Rep       Date:  2020-04-04       Impact factor: 4.806

Review 6.  Cutaneous lupus erythematosus: diagnosis and treatment.

Authors:  L G Okon; V P Werth
Journal:  Best Pract Res Clin Rheumatol       Date:  2013-06       Impact factor: 4.098

7.  Severe Granulomatous Rosacea with Cutaneous Lupus Erythematosus.

Authors:  Rym Afiouni; Josiane Helou; Stephanie Matar; Roland Tomb
Journal:  J Clin Aesthet Dermatol       Date:  2021-02-01

8.  [Cutaneous drug reactions imitating dermatoses].

Authors:  N Magnolo; T Schwarz; S Ständer
Journal:  Hautarzt       Date:  2014-05       Impact factor: 0.751

9.  Is there an association between alopecia areata and systemic lupus erythematosus? A population-based study.

Authors:  Khalaf Kridin; Guy Shalom; Doron Comaneshter; Arnon D Cohen
Journal:  Immunol Res       Date:  2020-02       Impact factor: 2.829

Review 10.  Pathogenesis and targeted treatment of skin injury in SLE.

Authors:  Guo-Min Deng; George C Tsokos
Journal:  Nat Rev Rheumatol       Date:  2015-08-04       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.